We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

71 hedge funds and large institutions have $310M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 9

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

56% more capital invested

Capital invested by funds: $198M → $310M (+$112M)

16% more funds holding

Funds holding: 61 → 71 (+10)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
34
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$11.2M
2
Millennium Management
Millennium Management
New York
+$10.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.53M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.67M
5
WSA
Wall Street Associates
California
+$4.47M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.04M
2
DCM
Driehaus Capital Management
Illinois
-$1.05M
3
Morgan Stanley
Morgan Stanley
New York
-$836K
4
Jennison Associates
Jennison Associates
New York
-$425K
5
PP
PDT Partners
New York
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
IHM
26
Iguana Healthcare Management
New York
$2.31M +$1.91M +90,000 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.87M +$409K +19,239 +36%
DCM
28
Driehaus Capital Management
Illinois
$1.71M -$1.05M -49,288 -42%
JGC
29
J. Goldman & Co
New York
$1.35M +$1.12M +52,500 New
LOAMU
30
Lombard Odier Asset Management (USA)
New York
$1.32M +$1.09M +51,400 New
TCIM
31
TIAA CREF Investment Management
New York
$1.26M -$29K -1,362 -3%
State of New Jersey Common Pension Fund D
32
State of New Jersey Common Pension Fund D
New Jersey
$1.11M – – –
GPCM
33
Granite Point Capital Management
Massachusetts
$1.03M +$851K +40,000 New
GACM
34
Green Arrow Capital Management
New York
$1.03M +$851K +40,000 New
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$895K +$742K +34,856 New
PAAMCP
36
Pacific Alternative Asset Management Company (PAAMCO)
California
$881K +$730K +34,316 New
SKK
37
Shepherd Kaplan Krochuk
Massachusetts
$723K +$59.1K +2,780 +11%
BIM
38
BlackRock Investment Management
Delaware
$695K +$72.2K +3,392 +14%
Charles Schwab
39
Charles Schwab
California
$595K +$111K +5,230 +29%
TC
40
TFS Capital
Pennsylvania
$473K +$392K +18,437 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$441K +$52.8K +2,484 +17%
BACM
42
Blue Arrow Capital Management
New York
$385K +$319K +15,000 New
BA
43
BlackRock Advisors
Delaware
$317K +$36.7K +1,723 +16%
PP
44
Paloma Partners
Connecticut
$303K +$251K +11,790 New
Deutsche Bank
45
Deutsche Bank
Germany
$270K +$196K +9,203 +684%
Swiss National Bank
46
Swiss National Bank
Switzerland
$264K +$91.5K +4,300 +72%
TA
47
Teachers Advisors
New York
$243K -$52.8K -2,480 -21%
CS
48
Credit Suisse
Switzerland
$237K +$196K +9,211 New
NFA
49
Nationwide Fund Advisors
Ohio
$223K +$20.6K +968 +13%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$207K +$171K +8,049 New
1
2
3 4

ASPX Hedge Fund Activity: Q3 2014 in Review

71 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q3 2014, worth a combined $310M — up 56% from $198M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ASPX positions and 9 closed out — a net gain of 10 holders — while 34 added to existing stakes and 9 trimmed.

The largest buyer was Deerfield Management, adding an estimated $11.2M. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.04M sold.

  • 71 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q3 2014, up from 61 in Q2 2014.
  • Funds reported $310M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, up 56% quarter-over-quarter.
  • 19 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 9 closed out, a net change of +10 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2014 was Deerfield Management, an estimated $11.2M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was Wellington Management Group, an estimated $2.04M sold.

Based on aggregated 13F filings for Q3 2014.